Glypican 3 Antibody (GPC3/8127R) [Janelia Fluor® 669]
Novus Biologicals, part of Bio-Techne | Catalog # NBP3-20870JF669
Recombinant Monoclonal Antibody
Conjugate
Catalog #
Forumulation
Catalog #
Key Product Details
Species Reactivity
Validated:
Human
Applications
Immunohistochemistry-Paraffin
Label
Janelia Fluor 669
Antibody Source
Recombinant Monoclonal Rabbit IgG Kappa Clone # GPC3/8127R
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Product Summary for Glypican 3 Antibody (GPC3/8127R) [Janelia Fluor® 669]
Immunogen
Recombinant fragment (around aa400-550) of human Glypican 3 protein (exact sequence is proprietary)
Localization
Cytoplasm.
Clonality
Monoclonal
Host
Rabbit
Isotype
IgG Kappa
Applications for Glypican 3 Antibody (GPC3/8127R) [Janelia Fluor® 669]
Application
Recommended Usage
Immunohistochemistry-Paraffin
Optimal dilutions of this antibody should be experimentally determined.
Application Notes
Optimal dilution of this antibody should be experimentally determined.
Please Note: Optimal dilutions of this antibody should be experimentally determined.
Formulation, Preparation, and Storage
Purification
Protein A purified
Formulation
50mM Sodium Borate
Preservative
0.05% Sodium Azide
Concentration
Please see the vial label for concentration. If unlisted please contact technical services.
Shipping
The product is shipped with polar packs. Upon receipt, store it immediately at the temperature recommended below.
Stability & Storage
Store at 4C in the dark.
Background: Glypican 3
Alternate Names
GPC3
Gene Symbol
GPC3
Additional Glypican 3 Products
Product Documents for Glypican 3 Antibody (GPC3/8127R) [Janelia Fluor® 669]
Product Specific Notices for Glypican 3 Antibody (GPC3/8127R) [Janelia Fluor® 669]
Sold under license from the Howard Hughes Medical Institute, Janelia Research Campus.
This product is for research use only and is not approved for use in humans or in clinical diagnosis. Primary Antibodies are guaranteed for 1 year from date of receipt.
Loading...
Loading...
Loading...
Loading...